neuroendocrine

You have access
Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes
Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip Just Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner

Journal of Nuclear Medicine September 9, 2021, jnumed.121.262506; DOI: https://doi.org/10.2967/jnumed.121.262506
You have access
Response to combined peptide receptor radionuclide therapy and checkpoint immunotherapy with ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
Justin Ferdinandus, Wolfgang Peter Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen Christian Becker and Selma Ugurel

Journal of Nuclear Medicine September 2, 2021, jnumed.121.262344; DOI: https://doi.org/10.2967/jnumed.121.262344
You have access
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
Sonya Youngju Park, Ashwin Singh Parihar, Lisa Bodei, Thomas A. Hope, Nadine Mallak, Corina Millo, Kalpna Prasad, Don Wilson, Katherine Zukotynski and Erik Mittra

Journal of Nuclear Medicine July 22, 2021, jnumed.120.251512; DOI: https://doi.org/10.2967/jnumed.120.251512
You have access
Dosimetric quantities of neuroendocrine tumors over treatment cycles with ¹⁷⁷Lu-DOTA-TATE
Daniel Roth, Johan Ruben Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262069; DOI: https://doi.org/10.2967/jnumed.121.262069
You have access
Values of ⁶⁸Ga-DOTATOC and Carbidopa-assisted ¹⁸F-DOPA PET/CT for insulinoma localization
Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb

Journal of Nuclear Medicine July 16, 2021, jnumed.121.262401; DOI: https://doi.org/10.2967/jnumed.121.262401
You have access
Efficacy and safety of ¹⁷⁷Lu-DOTATATE in lung neuroendocrine tumors: a bi-center study
Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J. Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J. Hicks, Simona Grozinsky-Glasberg and Grace Kong

Journal of Nuclear Medicine May 28, 2021, jnumed.120.260760; DOI: https://doi.org/10.2967/jnumed.120.260760
Open Access
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE
Jonathan R. Strosberg, Rajaventhan Srirajaskanthan, Ghassan El-Haddad, Edward M. Wolin, Beth R. Chasen, Matthew H. Kulke, David L. Bushnell, Martyn E. Caplin, Richard P Baum, Andrew E. Hendifar, Kjell Öberg, Philippe Ruszniewski, Paola Santoro, Per Broberg, Oscar R. Leeuwenkamp and Eric P. Krenning

Journal of Nuclear Medicine March 26, 2021, jnumed.120.258897; DOI: https://doi.org/10.2967/jnumed.120.258897
You have access
Semi-automatic tumor delineation for evaluation of ⁶⁴Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, Andreas Pfeifer, Peter Oturai, Seppo Wang Langer, Ulrich Knigge, Claes Nøhr Ladefoged and Andreas Kjaer

Journal of Nuclear Medicine February 26, 2021, jnumed.120.258392; DOI: https://doi.org/10.2967/jnumed.120.258392
You have access
A Prospective Randomized, Double-blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of ⁶⁸Ga-NODAGA-LM3 and ⁶⁸Ga-DOTA-LM3 in Patients with Well-differentiated Neuroendocrine Tumors
li huo, Wenjia Zhu, Yuejuan Cheng, Ru Jia, Hong Zhao, Chunmei Bai, Jianming Xu and Shaobo Yao

Journal of Nuclear Medicine February 12, 2021, jnumed.120.253096; DOI: https://doi.org/10.2967/jnumed.120.253096
You have access
First-in-Human Application of Terbium-161: A Feasibility Study Using ¹⁶¹Tb-DOTATOC
Richard P. Baum, Aviral Singh, Harshad R. Kulkarni, Peter Bernhardt, Tobias Rydén, Christiane Schuchardt, Nadezda Gracheva, Pascal V. Grundler, Ulli Köster, Dirk Müller, Michael Pröhl, Jan Rijn Zeevaart, Roger Schibli, Nicholas Philip Van der Meulen and Cristina Müller

Journal of Nuclear Medicine February 5, 2021, jnumed.120.258376; DOI: https://doi.org/10.2967/jnumed.120.258376

Main menu

User menu

Search

neuroendocrine

Pages